Author
Listed:
- Eitan Kugler
(Tel Aviv University
Davidoff Cancer Center, Rabin Medical Center)
- Shreyas Madiwale
(Tel Aviv University
The Rina Zaizov Pediatric Hematology and Oncology Division Schneider Children’s Medical Center of Israel)
- Darren Yong
(University Health Network
University of Toronto)
- Julie A. I. Thoms
(Lowy Cancer Research Centre, UNSW Sydney
Faculty of Medicine, UNSW Sydney)
- Yehudit Birger
(Tel Aviv University
The Rina Zaizov Pediatric Hematology and Oncology Division Schneider Children’s Medical Center of Israel)
- David B. Sykes
(Massachusetts General Hospital, Boston, MA, USA & Harvard Stem Cell Institute)
- Johannes Schmoellerl
(Vienna BioCenter (VBC))
- Aneta Drakul
(University Children’s Hospital)
- Valdemar Priebe
(University Children’s Hospital)
- Muhammad Yassin
(Tel Aviv University)
- Nasma Aqaqe
(Tel Aviv University)
- Avigail Rein
(Tel Aviv University
The Rina Zaizov Pediatric Hematology and Oncology Division Schneider Children’s Medical Center of Israel)
- Hila Fishman
(Tel Aviv University
The Rina Zaizov Pediatric Hematology and Oncology Division Schneider Children’s Medical Center of Israel)
- Ifat Geron
(Tel Aviv University
The Rina Zaizov Pediatric Hematology and Oncology Division Schneider Children’s Medical Center of Israel)
- Chun-Wei Chen
(Beckman Research Institute, City of Hope
Dana-Farber Cancer Institute, Harvard Medical School
City of Hope Comprehensive Cancer Center)
- Brian Raught
(University Health Network)
- Qiao Liu
(Beckman Research Institute, City of Hope)
- Heather Ogana
(University of Southern California)
- Elisabeth Liedke
(University Health Network
University of Toronto)
- Jean-Pierre Bourquin
(University Children’s Hospital)
- Johannes Zuber
(Vienna BioCenter (VBC)
Medical University of Vienna)
- Michael Milyavsky
(Tel Aviv University)
- John Pimanda
(Lowy Cancer Research Centre, UNSW Sydney
Faculty of Medicine, UNSW Sydney)
- Gilbert G. Privé
(University Health Network
University of Toronto)
- Shai Izraeli
(Tel Aviv University
The Rina Zaizov Pediatric Hematology and Oncology Division Schneider Children’s Medical Center of Israel)
Abstract
The ERG (ETS-related gene) transcription factor is linked to various types of cancer, including leukemia. However, the specific ERG domains and co-factors contributing to leukemogenesis are poorly understood. Drug targeting a transcription factor such as ERG is challenging. Our study reveals the critical role of a conserved amino acid, proline, at position 199, located at the 3’ end of the PNT (pointed) domain, in ERG’s ability to induce leukemia. P199 is necessary for ERG to promote self-renewal, prevent myeloid differentiation in hematopoietic progenitor cells, and initiate leukemia in mouse models. Here we show that P199 facilitates ERG’s interaction with the NCoR-HDAC3 co-repressor complex. Inhibiting HDAC3 reduces the growth of ERG-dependent leukemic and prostate cancer cells, indicating that the interaction between ERG and the NCoR-HDAC3 co-repressor complex is crucial for its oncogenic activity. Thus, targeting this interaction may offer a potential therapeutic intervention.
Suggested Citation
Eitan Kugler & Shreyas Madiwale & Darren Yong & Julie A. I. Thoms & Yehudit Birger & David B. Sykes & Johannes Schmoellerl & Aneta Drakul & Valdemar Priebe & Muhammad Yassin & Nasma Aqaqe & Avigail Re, 2023.
"The NCOR-HDAC3 co-repressive complex modulates the leukemogenic potential of the transcription factor ERG,"
Nature Communications, Nature, vol. 14(1), pages 1-20, December.
Handle:
RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-41067-2
DOI: 10.1038/s41467-023-41067-2
Download full text from publisher
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.
- Zeinab Asgarian & Marcio Guiomar Oliveira & Agata Stryjewska & Ioannis Maragkos & Anna Noren Rubin & Lorenza Magno & Vassilis Pachnis & Mohammadmersad Ghorbani & Scott Wayne Hiebert & Myrto Denaxa & N, 2022.
"MTG8 interacts with LHX6 to specify cortical interneuron subtype identity,"
Nature Communications, Nature, vol. 13(1), pages 1-15, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-41067-2. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.